Current Report Filing (8-k)
11 1월 2018 - 7:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
January 9, 2018
____________________________
MEDICAL IMAGING CORP.
(Exact name of registrant as specified in charter)
NEVADA
(State or other Jurisdiction of Incorporation or Organization)
|
| |
333-1364363
|
848 N. Rainbow Blvd. #2494
Las Vegas, Nevada 89107
|
98-0493698
|
(Commission File Number)
|
(Address of Principal Executive Offices and zip code)
|
(IRS Employer Identification No.)
|
(877) 331-3444
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 4.01 Changes in Registrants Certifying Accountant
On January 9, 2018, Medical Imaging Corp. (the Company) terminated Accell Audit & Compliance, PA (Accell) as the Companys principal independent accountant.
Accell was engaged as the Companys principal independent accountant on September 21, 2015 and reported on the Companys financial statements for the fiscal years ended December 31, 2015 and December 31, 2016. During the Companys last fiscal year, and subsequently up to the date of resignation, there were no disagreements between the Company and Accell on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements that, if not resolved to Accells satisfaction, would have caused Accell to make reference to the subject matter of the disagreement in connection with its report issued in connection with the audit of the Companys financial statements.
None of the reportable events described under Item 304(a)(1)(v)(A)-(D) of Regulation S-K occurred within the Companys last fiscal year nor subsequently up to the date of dismissal.
Accells audit report on the Companys financial statements for the fiscal year ended December 31, 2016 contained no adverse opinion or disclaimer of opinion, however it was qualified as to uncertainty as a going concern.
The Company provided Accell with a copy of this disclosure before its filing with the Securities and Exchange Commission (the SEC), providing Accell with the opportunity to furnish the Company with a letter addressed to the SEC stating whether it agrees with the disclosures made in the filing. A letter from Accell is attached as Exhibit 16.1 to this filing.
The Company has engaged AMC Auditing as its new audit firm.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
16.1
Letter from Accell Audit & Compliance, PA
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
|
| |
|
Medical Imaging Corp.
|
|
(Registrant)
|
|
|
|
|
|
|
Dated: January 9, 2018
|
By:
|
/s/ Mitchell Geisler
|
|
|
Name: Mitchell Geisler
|
|
|
Title: Chief Executive Officer
|
3
Medical Imaging (CE) (USOTC:MEDD)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Medical Imaging (CE) (USOTC:MEDD)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Medical Imaging Corporation (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Medical Imaging Corp. News Articles